|
gptkbp:instanceOf
|
gptkb:chemical_compound
cardiac glycoside
|
|
gptkbp:ATCCode
|
C01AA04
|
|
gptkbp:CASNumber
|
71-63-6
|
|
gptkbp:chemicalFormula
|
C41H64O13
|
|
gptkbp:discoveredIn
|
1875
|
|
gptkbp:eliminationHalfLife
|
5–7 days
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:foundIn
|
gptkb:Digitalis_purpurea
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
digitoxin
|
|
gptkbp:IUPACName
|
3β-[(O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide
|
|
gptkbp:KEGGID
|
D07882
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits Na+/K+-ATPase
|
|
gptkbp:meltingPoint
|
238–239 °C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
764.94 g/mol
|
|
gptkbp:PubChem_CID
|
CHEMBL1409
2006931
2724385
DB01396
|
|
gptkbp:relatedTo
|
gptkb:digoxin
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gptkb:arrhythmia
nausea
vomiting
visual disturbances
|
|
gptkbp:solubility
|
practically insoluble in water
|
|
gptkbp:toxicity
|
narrow therapeutic index
|
|
gptkbp:UNII
|
73K4184T59
|
|
gptkbp:usedFor
|
treatment of heart failure
treatment of atrial fibrillation
|
|
gptkbp:bfsParent
|
gptkb:Digitalis
gptkb:convallatoxin
gptkb:Cardenolides
gptkb:Digitalis_purpurea
|
|
gptkbp:bfsLayer
|
6
|